Cleared Traditional

K984258 - NEUROVASX SUB-MICROINFUSION CATHETER

K984258 is an FDA 510(k) clearance for NEUROVASX SUB-MICROINFUSION CATHETER, manufactured by Neuro Vasx, Inc.. The device is a Class 2 Cardiovascular device with product code DQO cleared through the Traditional 510(k) pathway after a 73-day FDA review.

K984258 · Neuro Vasx, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1999
Decision
73d
Days
Class 2
Risk

K984258 is an FDA 510(k) clearance for the NEUROVASX SUB-MICROINFUSION CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Neuro Vasx, Inc. (Plymouth, US). The FDA issued a Cleared decision on February 11, 1999 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Neuro Vasx, Inc. devices

FDA 510(k) Submission Details - K984258

510(k) Number K984258 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 1998
Decision Date February 11, 1999
Days to Decision 73 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 125d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQO Device Classification - Class 2, Special Controls

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 400
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K984258.
AVE 4F SITESEER CARDIOVASCULAR ANGIOGRAPHIC CATHETER
K984627 · Arterial Vascular Engineering, Inc. · Jul 1999
SCIMED ANGIOGRAPHIC CATHETERS
K992142 · Scimed · Jul 1999
CORDIS TEMPO ANGIOGRAPHY CATHETER
K991673 · Cordis Corp. · May 1999
MEDTRONIC ANGIOGRAPHIC CATHETER
K980973 · Medtronics Interventional Vascular · Dec 1998
BLOOD PRESSURE MEASUREMENT SYSTEM(DSPM-70)
K971616 · Data Sciences Intl., Inc. · Nov 1998
SPYGLASS 5 FR ANGIOGRAPHIC CATHETER
K982299 · Daig Corp. · Oct 1998